FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rajiv Sharma

Research Profile

Disorders

Concepts & Ideas

Psychiatric Status Rating Scales

Activities & Behaviors

Schizophrenic Psychology

Chemicals & Drugs

Physiology

Procedures

Double-Blind Method

Anatomy

Co-author Network

Publications

TOP 3
Kayla A Chase; Rajiv P Sharma
Nicotine induces chromatin remodelling through decreases in the methyltransferases GLP, G9a, Setdb1 and levels of H3K9me2.
Rajiv P Sharma
Blood chromatin as a biosensor of the epigenetic milieu: a tool for studies in living psychiatric patients.
Rajiv P Sharma; David Peter Gavin; K A Chase
Heterochromatin as an incubator for pathology and treatment non-response: implication for neuropsychiatric illness.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rajiv Sharma (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kayla A Chase; Rajiv P Sharma
Nicotine induces chromatin remodelling through decreases in the methyltransferases GLP, G9a, Setdb1 and levels of H3K9me2.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2013;16(5):1129-38.
2012: Rajiv P Sharma
Blood chromatin as a biosensor of the epigenetic milieu: a tool for studies in living psychiatric patients.
Epigenomics 2012;4(5):551-9.
2012: Rajiv P Sharma; David Peter Gavin; K A Chase
Heterochromatin as an incubator for pathology and treatment non-response: implication for neuropsychiatric illness.
The pharmacogenomics journal 2012;12(5):361-7.
2012: Rajiv P Sharma; Kayla A Chase
Increasing neuronal 'stemness': chromatin relaxation and the expression of reprogramming genes in post-mitotic neurons.
Medical hypotheses 2012;78(4):553-4.
2012: David Peter Gavin; Erbo Dong; Rajiv P Sharma; Kayla A Chase; Francesco Matrisciano; Alessandro Guidotti
Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2012;37(2):531-42.
2011: David Peter Gavin; Kayla A Chase; Rajiv P Sharma
Enhancement of psychotherapy using epigenetic modulating drugs.
Medical hypotheses 2011;77(1):121-4.
2011: Alessandro Guidotti; James Auta; Ying Chen; John M Davis; Erbo Dong; David Peter Gavin; Dennis Grayson; Francesco Matrisciano; Graziano Pinna; R Satta; Rajiv P Sharma; Lucio Tremolizzo; Patricia Tueting
Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
Neuropharmacology 2011;60(7-8):1007-16.
2010: Rajiv P Sharma; David Peter Gavin; Dennis Grayson
CpG methylation in neurons: message, memory, or mask?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(10):2009-20.
2010: David Peter Gavin; Rajiv P Sharma
Histone modifications, DNA methylation, and schizophrenia.
Neuroscience and biobehavioral reviews 2010;34(6):882-8.
2010: Dennis Grayson; Marija Kundakovic; Rajiv P Sharma
Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?
Molecular pharmacology 2010;77(2):126-35.
2009: David Peter Gavin; Saritha Kartan; Kayla Chase; Sundararajan Jayaraman; Rajiv P Sharma
Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population.
Journal of psychiatric research 2009;43(9):870-6.
2009: David Peter Gavin; Cherise Rosen; Kayla Chase; Dennis Grayson; Nguwah Tun; Rajiv P Sharma
Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures.
Journal of psychiatry & neuroscience : JPN 2009;34(3):232-7.
2009: Marta Imbesi; S Yildiz; A Dirim Arslan; Rajiv P Sharma; Hari Manev; Tolga Uz
Dopamine receptor-mediated regulation of neuronal "clock" gene expression.
Neuroscience 2009;158(2):537-44.
2009: David Peter Gavin; Rajiv P Sharma
Chromatin from peripheral blood mononuclear cells as biomarkers for epigenetic abnormalities in schizophrenia.
Cardiovascular psychiatry and neurology 2009;2009():409562.
2009: Marta Imbesi; Ahmet Dirim Arslan; Sevim Yildiz; Rajiv P Sharma; David Peter Gavin; Nguwah Tun; Hari Manev; Tolga Uz
The melatonin receptor MT1 is required for the differential regulatory actions of melatonin on neuronal 'clock' gene expression in striatal neurons in vitro.
Journal of pineal research 2009;46(1):87-94.
2008: Marta Imbesi; Tolga Uz; Radmila Manev; Rajiv P Sharma; Hari Manev
Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors.
Neuroscience letters 2008;447(2-3):134-7.
2008: David Peter Gavin; Saritha Kartan; Kayla Chase; Dennis Grayson; Rajiv P Sharma
Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects.
Schizophrenia research 2008;103(1-3):330-2.
2008: Rajiv P Sharma; Nguwah Tun; Dennis Grayson
Depolarization induces downregulation of DNMT1 and DNMT3a in primary cortical cultures.
Epigenetics : official journal of the DNA Methylation Society 2008;3(2):74-80.
2008: Rajiv P Sharma; Dennis Grayson; David Peter Gavin
Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection.
Schizophrenia research 2008;98(1-3):111-7.
2007: Marta Imbesi; Iris Zavoreo; Tolga Uz; Rajiv P Sharma; Nikola Dimitrijevic; Hari Manev; Radmila Manev
5-Lipoxygenase inhibitor MK-886 increases GluR1 phosphorylation in neuronal cultures in vitro and in the mouse cortex in vivo.
Brain research 2007;1147():148-53.
2007: Cherise Rosen; Linda S Grossman; Rajiv P Sharma; Carl C Bell; Russ Mullner; Henry W Dove
Subjective evaluations of research participation by persons with mental illness.
The Journal of nervous and mental disease 2007;195(5):430-5.
2006: Rajiv P Sharma; Cherise Rosen; Saritha Kartan; Alessandro Guidotti; Erminio Costa; Dennis Grayson; Kayla Chase
Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population.
Schizophrenia research 2006;88(1-3):227-31.
2006: Dennis Grayson; Ying Chen; Erminio Costa; Erbo Dong; Alessandro Guidotti; Marija Kundakovic; Rajiv P Sharma
The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia.
Pharmacology & therapeutics 2006;111(1):272-86.
2005: Rajiv P Sharma; Dennis Grayson; Alessandro Guidotti; Erminio Costa
Chromatin, DNA methylation and neuron gene regulation--the purpose of the package.
Journal of psychiatry & neuroscience : JPN 2005;30(4):257-63.
2005: Dennis Grayson; Xiaomei Jia; Ying Chen; Rajiv P Sharma; Colin P Mitchell; Alessandro Guidotti; Erminio Costa
Reelin promoter hypermethylation in schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(26):9341-6.
2005: Jai Sung Noh; Rajiv P Sharma; Marin Veldic; Alain A Salvacion; Xiaomei Jia; Ying Chen; Erminio Costa; Alessandro Guidotti; Dennis Grayson
DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(5):1749-54.
2005: Rajiv P Sharma
Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics.
Schizophrenia research 2005;72(2-3):79-90.
2003: Brian Martis; Danesh Alam; Sheila M Dowd; S Kristian Hill; Rajiv P Sharma; Cherise Rosen; Neil H Pliskin; Eileen Martin; Valorie Carson; Philip G Janicak
Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2003;114(6):1125-32.
2002: Lucio Tremolizzo; Giovanni Carboni; William Ruzicka; Colin P Mitchell; Ikuko Sugaya; Patricia Tueting; Rajiv P Sharma; Dennis Grayson; Erminio Costa; Alessandro Guidotti
An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(26):17095-100.
2002: Ying Chen; Rajiv P Sharma; Robert H Costa; Erminio Costa; Dennis Grayson
On the epigenetic regulation of the human reelin promoter.
Nucleic acids research 2002;30(13):2930-9.
2002: Philip G Janicak; Sheila M Dowd; Brian Martis; Danesh Alam; Dennis D. Beedle; Jack S Krasuski; Mary Jane Strong; Rajiv P Sharma; Cherise Rosen; Marlos Viana
Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial.
Biological psychiatry 2002;51(8):659-67.
2002: Ghanshyam N Pandey; Yogesh Dwivedi; Jagadeesh SridharaRao; Xinguo Ren; Philip G Janicak; Rajiv P Sharma
Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(2):216-28.
2001: Ghanshyam N Pandey; X Ren; Subhash C Pandey; Yogesh Dwivedi; Rajiv P Sharma; Philip G Janicak
Hyperactive phosphoinositide signaling pathway in platelets of depressed patients: effect of desipramine treatment.
Psychiatry research 2001;105(1-2):23-32.
2001: Rajiv P Sharma; Brian Martis; Cherise Rosen; J Jonalagadda; Charles Nemeroff; Garth Bissette
CSF thyrotropin-releasing hormone concentrations differ in patients with schizoaffective disorder from patients with schizophrenia or mood disorders.
Journal of psychiatric research 2001;35(5):287-91.
2001: Philip G Janicak; P E Keck; John M Davis; J W Kasckow; K Tugrul; Sheila M Dowd; J Strong; Rajiv P Sharma; S M Strakowski
A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.
Journal of clinical psychopharmacology 2001;21(4):360-8.
2001: Rajiv P Sharma; Brian Martis; John M Davis; R Omens; Philip G Janicak
Tiagabine, a specific gamma-aminobutyric acid transporter-1 inhibitor, in the treatment of psychosis.
Journal of clinical psychopharmacology 2001;21(3):347-9.
2000: Alessandro Guidotti; James Auta; John M Davis; V Di-Giorgi-Gerevini; Yogesh Dwivedi; Dennis Grayson; F Impagnatiello; Ghanshyam N Pandey; Christine Pesold; Rajiv P Sharma; Doncho P Uzunov; Erminio Costa; V DiGiorgi Gerevini
Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.
Archives of general psychiatry 2000;57(11):1061-9.
1999: Rajiv P Sharma; Vivek Singh; Philip G Janicak; Javaid I Javaid; Ghanshyam N Pandey
The prolactin response to fenfluramine in schizophrenia is associated with negative symptoms.
Schizophrenia research 1999;39(1):85-9.
1999: Rajiv P Sharma; Sheila M Dowd; Philip G Janicak
Hallucinations in the acute schizophrenic-type psychosis: effects of gender and age of illness onset.
Schizophrenia research 1999;37(1):91-5.
1998: F Impagnatiello; Alessandro Guidotti; Christine Pesold; Yogesh Dwivedi; Hector Caruncho; MG Pisu; Doncho P Uzunov; Neil R Smalheiser; John M Davis; Ghanshyam N Pandey; George D Pappas; Patricia Tueting; Rajiv P Sharma; Erminio Costa
A decrease of reelin expression as a putative vulnerability factor in schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(26):15718-23.
1998: Rajiv P Sharma; Javaid I Javaid; John M Davis; Philip G Janicak
Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective disorder: the influence of demographic variables and the inpatient drug-free period.
Biological psychiatry 1998;44(6):488-92.
1998: Philip G Janicak; Rajiv P Sharma; Ghanshyam N Pandey; John M Davis
Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial.
The American journal of psychiatry 1998;155(7):972-3.
1997: Rajiv P Sharma; Philip G Janicak; Garth Bissette; Charles Nemeroff
CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder.
The American journal of psychiatry 1997;154(7):1019-21.
1997: Philip G Janicak; Javaid I Javaid; Rajiv P Sharma; A Leach; S Dowd; John M Davis
A two-phase, double-blind randomized study of three haloperidol plasma levels for acute psychosis with reassignment of initial non-responders.
Acta psychiatrica Scandinavica 1997;95(4):343-50.
1997: Rajiv P Sharma; L E Shapiro; Savitri K Kamath; E A Soll; M D Watanabe; John M Davis
Acute dietary tryptophan depletion: effects on schizophrenic positive and negative symptoms.
Neuropsychobiology 1997;35(1):5-10.
1996: Rajiv P Sharma; S M Dowd; John M Davis; Philip G Janicak
Age of illness onset and schizophrenic symptomatology during an inpatient washout period.
Schizophrenia research 1996;20(3):295-300.
1996: Javaid I Javaid; Philip G Janicak; Rajiv P Sharma; A M Leach; John M Davis; Z Wang
Prediction of haloperidol steady-state levels in plasma after a single test dose.
Journal of clinical psychopharmacology 1996;16(1):45-50.
1995: Rajiv P Sharma; Garth Bissette; Philip G Janicak; John M Davis; Charles Nemeroff
Elevation of CSF somatostatin concentrations in mania.
The American journal of psychiatry 1995;152(12):1807-9.
1995: Ghanshyam N Pandey; Subhash C Pandey; Yogesh Dwivedi; Rajiv P Sharma; Philip G Janicak; John M Davis
Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior.
The American journal of psychiatry 1995;152(6):850-5.
1995: Rajiv P Sharma; K Faull; Javaid I Javaid; John M Davis
Cerebrospinal fluid levels of phenylacetic acid in mental illness: behavioral associations and response to neuroleptic treatment.
Acta psychiatrica Scandinavica 1995;91(5):293-8.
1994: Rajiv P Sharma; Garth Bissette; Philip G Janicak; John M Davis; Charles Nemeroff
Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder: the effects of antipsychotic treatment.
Schizophrenia research 1994;13(2):173-7.
1994: Rajiv P Sharma; Javaid I Javaid; K Faull; John M Davis; Philip G Janicak
CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatments.
Psychiatry research 1994;51(1):51-60.
1993: Rajiv P Sharma; Javaid I Javaid; Philip G Janicak; John M Davis; K Faull
Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment.
Biological psychiatry 1993;34(3):128-34.
1993: Subhash C Pandey; Rajiv P Sharma; Philip G Janicak; Robert C. Marks; John M Davis; Ghanshyam N Pandey
Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.
Psychiatry research 1993;48(1):57-68.
1992: Ghanshyam N Pandey; Rajiv P Sharma; Philip G Janicak; John M Davis
Monoamine oxidase and cortisol response in depression and schizophrenia.
Psychiatry research 1992;44(1):1-8.
1992: Rajiv P Sharma; P N Venkatasubramanian; Michael Bárány; John M Davis
Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients.
Schizophrenia research 1992;8(1):43-9.
1992: Rajiv P Sharma; Donald Hedeker; Ghanshyam N Pandey; Philip G Janicak; John M Davis
A longitudinal study of plasma cortisol and depressive symptomatology by random regression analysis.
Biological psychiatry 1992;31(3):304-14.
1992: John M Davis; Philip G Janicak; Z Wang; Robert D Gibbons; Rajiv P Sharma
The efficacy of psychotropic drugs: implications for power analysis.
Psychopharmacology bulletin 1992;28(2):151-5.
1991: Rajiv P Sharma; Javaid I Javaid; Ghanshyam N Pandey; Philip G Janicak; John M Davis
Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients.
Biological psychiatry 1991;30(5):459-66.
1991: Javaid I Javaid; Philip G Janicak; Donald Hedeker; Rajiv P Sharma; John M Davis
Steady-state plasma level prediction for haloperidol from a single test dose.
Psychopharmacology bulletin 1991;27(1):83-8.
1991: Philip G Janicak; Rajiv P Sharma; T H Israni; S M Dowd; E Altman; John M Davis
Effects of unilateral-nondominant vs. bilateral ECT on memory and depression: a preliminary report.
Psychopharmacology bulletin 1991;27(3):353-7.
1991: D Holland; M D Watanabe; Rajiv P Sharma
Atypical antipsychotics.
Psychiatric medicine 1991;9(1):5-24.
1990: Rajiv P Sharma; Philip G Janicak; Javaid I Javaid; Ghanshyam N Pandey; B Gierl; John M Davis
Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine.
The American journal of psychiatry 1990;147(10):1318-21.
1990: Rajiv P Sharma; J I Javaid; Ghanshyam N Pandey; M Easton; John M Davis
Pharmacological effects of methylphenidate on plasma homovanillic acid and growth hormone.
Psychiatry research 1990;32(1):9-17.
1990: D B Bresnahan; Ghanshyam N Pandey; Philip G Janicak; Rajiv P Sharma; R A Boshes; S S Chang; B L Gierl; John M Davis
MAO inhibition and clinical response in depressed patients treated with phenelzine.
The Journal of clinical psychiatry 1990;51(2):47-50.
1990: Javaid I Javaid; Rajiv P Sharma; Philip G Janicak; John M Davis
Plasma HVA in psychiatric patients: longitudinal studies.
Psychopharmacology bulletin 1990;26(3):361-5.
1990: J E Comaty; Philip G Janicak; J Rajaratnam; Rajiv P Sharma; D Baker; John M Davis
Is maintenance antiparkinsonian treatment necessary?
Psychopharmacology bulletin 1990;26(2):267-70.
1989: Philip G Janicak; Javaid I Javaid; Rajiv P Sharma; J E Comaty; J Peterson; John M Davis
Trifluoperazine plasma levels and clinical response.
Journal of clinical psychopharmacology 1989;9(5):340-6.
1989: Rajiv P Sharma; Javaid I Javaid; Philip G Janicak; K Faull; J Comaty; John M Davis
Plasma and CSF HVA before and after pharmacological treatment.
Psychiatry research 1989;28(1):97-104.
1989: Philip G Janicak; Rajiv P Sharma; M Easton; J E Comaty; John M Davis
A double-blind, placebo-controlled trial of clonidine in the treatment of acute mania.
Psychopharmacology bulletin 1989;25(2):243-5.
1989: Philip G Janicak; J Lipinski; John M Davis; E Altman; Rajiv P Sharma
Parenteral S-adenosyl-methionine (SAMe) in depression: literature review and preliminary data.
Psychopharmacology bulletin 1989;25(2):238-42.
1988: Rajiv P Sharma; Javaid I Javaid; Philip G Janicak; J Comaty; John M Davis; K Faull
Effect of trifluoperazine on CSF and plasma HVA levels in schizophrenic subjects.
The American journal of psychiatry 1988;145(11):1480-1.
1988: Rajiv P Sharma; Ghanshyam N Pandey; Philip G Janicak; J Peterson; J E Comaty; John M Davis
The effect of diagnosis and age on the DST: a metaanalytic approach.
Biological psychiatry 1988;24(5):555-68.
1988: Philip G Janicak; J Lipinski; John M Davis; J E Comaty; C Waternaux; B Cohen; E Altman; Rajiv P Sharma
S-adenosylmethionine in depression. A literature review and preliminary report.
The Alabama journal of medical sciences 1988;25(3):306-13.
1988: Philip G Janicak; D B Bresnahan; Rajiv P Sharma; John M Davis; J E Comaty; C Malinick
A comparison of thiothixene with chlorpromazine in the treatment of mania.
Journal of clinical psychopharmacology 1988;8(1):33-7.
1988: Philip G Janicak; Ghanshyam N Pandey; John M Davis; R Boshes; D Bresnahan; Rajiv P Sharma
Response of psychotic and nonpsychotic depression to phenelzine.
The American journal of psychiatry 1988;145(1):93-5.
1987: Philip G Janicak; Ghanshyam N Pandey; Rajiv P Sharma; R Boshes; D Bresnahan; John M Davis
Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
The Journal of clinical psychiatry 1987;48(12):480-2.